The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (9 analysts) rates it buy, with a mean price target of $63. Insiders have been net sellers over the past quarter.
Cactus, Inc.
WHD · the NYSE · USD · Market cap $4.7B · 1,500 employees
Cactus, Inc., together with its subsidiaries, designs, manufactures, sells, and rents engineered pressure control and spoolable pipe technologies in the United States, Australia, Canada, the Middle East, and internationally.
PASS · Titan Ethical · score 70.0Price as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 20:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price55.01 USD at the 5 Nov 2026 close
- Our value readFair vs our fair value, as of 5 Nov 2026
- Our regime readMarkdown, as of 5 Nov 2026
- Ethical screenPasses, score 70.0 out of 100
- OptionsOpen interest leans heavily to calls (put/call 0.24)
- Last reviewed5 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $51.30 to $60.08, base estimate $52.24 (screen dated 2026-11-05).
- Trend Markdown
- Insiders insiders sold, $6,391,400, latest filing 2026-11-02
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.24, read 2026-11-05
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
Cactus, Inc. holds its Markdown at $55.01. Consolidating, no directional conviction, held for 3 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 3 days |
| Price at the screen | $55.01 |
| Valuation | 39.50 trailing · 16.10 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 1.36 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 2.02% | Below 33% | Interest-bearing debt is just 2.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 15.39% | Below 49% | Money owed to the company is 15.4% of assets, under the 49% limit. | Pass |
| Revenue purity | 1.42% | Below 5% | Only 1.4% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Clears, in Plain English
Cactus, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 2%, inside the ~33% line, and interest is about 1% of its income, under the ~5% line, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when WHD's ethical verdict changes
Today WHD passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 5 Nov 2026: it trades above our $52.24 fair value estimate, 63.20% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. The price runs 5.3% above the base estimate.
Third-party analyst targets: 9 covering, consensus Buy. The average target sits +35% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $52.24, with a range of $51.30 to $60.08, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsOil gear demand spikes then vanishes without warning
Picture a drilling crew in West Texas that needs pressure kit today and cancels the order tomorrow when crude dips. Cactus rides exactly those swings, posting 38% revenue growth and 13% margins while earning a 13% return on equity. The business clears our ethical screen, yet the shares sit 11% above our fair value at 15.2 times forward earnings, so we see no margin of safety and pass.
Analysts still rate the stock a buy with a 67 dollar median target, but that optimism often peaks right when the cycle does. Forward multiples in this sector can look reasonable only because earnings are inflated at the top; once rigs stack, both revenue and the multiple compress together.
The real risk is mistaking a low multiple for value when earnings have already crested. Currency moves and rig count drops have flattened similar names before, and nothing in the current numbers changes that pattern. Analysis, not advice.
| Forward P/E | 16.1xcheap for a company growing this fast |
| Trailing P/E | 39.5xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 1.47 |
| EPS, forward | 3.61 |
| Revenue growth | +63.2%growing very fast |
| Profit margin | 12.0%thin but positive margins |
| Return on equity | 14.2%a solid return on shareholder capital |
| FCF yield | 1.72% |
| Dividend yield | 95.00% |
| Debt to equity | 3.05heavy leverage: higher risk if revenue softens |
| Current ratio | 3.06comfortably covers its short-term bills |
| Beta | 1.36moves a little more than the market |
| Short interest, float | 0.05% |
| 52-week range | 39.16 - 74.07 |
| Market cap | $4.7B |
| Employees | 1,500 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeWHD trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (9 analysts) rates it buy, with a mean price target of $63. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (9 analysts) rates it buy, with a mean price target of $63. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 9% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (9 analysts) rates it buy, with a mean price target of $63. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (9 analysts) rates it buy, with a mean price target of $63. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (9 analysts) rates it buy, with a mean price target of $63. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (9 analysts) rates it buy, with a mean price target of $63. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (9 analysts) rates it buy, with a mean price target of $63. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (9 analysts) rates it buy, with a mean price target of $63. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 2.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 25%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (9 analysts) rates it buy, with a mean price target of $63. Insiders have been net sellers over the past quarter.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Cactus Q3 Earnings Call Highlights Yahoo Finance · 7d ago
- Does Earnings Beat Change The Bull Case For Cactus Stock (WHD)? Yahoo Finance · 7d ago
- Cactus (WHD) Q3 2026 Earnings Call Transcript Yahoo Finance · 8d ago
- Cactus, Inc. Q3 2026 Earnings Call Summary Yahoo Finance · 8d ago
- Cactus, Inc. (WHD) Beats Q3 Earnings and Revenue Estimates Yahoo Finance · 9d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-02 | Bender Scott | COB, CEO, 10% | S - Sale+OE | 100,000 | $6,391,400 |
| 2026-11-02 | Bender Joel | Pres, 10% | S - Sale+OE | 100,000 | $6,391,400 |
| 2026-10-01 | Bender Scott | COB, CEO, 10% | S - Sale+OE | 100,000 | $6,197,300 |
| 2026-10-01 | Bender Joel | Pres, 10% | S - Sale+OE | 100,000 | $6,197,300 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $56.39 | +3.0% | $0.14 | $1,032 | +3.2% |
| 2 months | $54.21 | +7.1% | $0.14 | $1,074 | +7.4% |
| 3 months | $45.89 | +26.6% | $0.14 | $1,269 | +26.9% |
| 6 months | $46.73 | +24.3% | $0.28 | $1,249 | +24.9% |
| 1 year | $46.38 | +25.2% | $0.56 | $1,264 | +26.4% |
| 2 years | $51.69 | +12.4% | $1.08 | $1,145 | +14.5% |
| 3 years | $38.87 | +49.4% | $1.56 | $1,534 | +53.4% |
| 5 years | $38.98 | +49.0% | $2.42 | $1,552 | +55.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever WHD does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.